Technology
Monday, October 21st, 2024 6:24 pm EDT
Key Points
- Introduction of CareIntellect for Oncology: GE HealthCare announced the launch of CareIntellect for Oncology, an AI application designed to assist oncologists by quickly summarizing patient history and disease progression, thus reducing the time spent sorting through complex healthcare data.
- Streamlining Clinical Processes: The tool not only summarizes clinical reports but also identifies when patients deviate from treatment plans and helps find relevant clinical trials, significantly reducing the workload for oncologists and allowing them to focus more on patient care.
- Future Developments and Integration: GE HealthCare plans to make CareIntellect widely available by 2025 and is exploring additional AI products, including Health Companion, which will leverage a team of AI agents to provide real-time support and insights to doctors, aiming to enhance the standard of care in oncology.
GE HealthCare recently announced its new AI tool, CareIntellect for Oncology, designed to improve the efficiency of oncologists by simplifying patient data analysis. This tool helps doctors quickly access relevant information about a cancer patient’s history and disease progression, saving them from the tedious task of navigating through complex medical records stored in various formats. The AI-powered platform aims to address the issue that up to 97% of healthcare data goes unused, as doctors often struggle to find meaningful insights amid overwhelming amounts of medical information.
CareIntellect for Oncology is capable of summarizing clinical reports and identifying deviations in patient treatment plans, such as missed lab tests, allowing doctors to make better-informed decisions. The tool also assists oncologists by identifying relevant clinical trials for which their patients may qualify, reducing the time spent searching through databases. The primary goal of CareIntellect is to streamline doctors’ workflows, but it also allows clinicians to delve into more detailed patient records if needed.
GE HealthCare plans to make CareIntellect available to U.S. customers in 2025, initially optimized for prostate and breast cancer treatments. Tampa General Hospital is already evaluating the tool. Since it is cloud-based, CareIntellect will generate recurring revenue for GE HealthCare. The company also plans to expand the CareIntellect brand with additional apps targeting other medical needs, allowing healthcare organizations to select the tools they want to use.
GE HealthCare is concurrently working on other AI innovations, including Health Companion, a concept tool featuring AI agents specialized in fields such as radiology and pathology. These AI agents could work together as a multidisciplinary team, providing doctors with instant insights to improve patient care. While still in development, the Health Companion tool aims to elevate the standard of care by offering immediate expert-level support to overburdened clinicians, which typically would take weeks when consulting a human panel of specialists.
Overall, GE HealthCare’s AI initiatives, including CareIntellect for Oncology and the future Health Companion, signal a significant push toward leveraging artificial intelligence to optimize healthcare delivery, reduce physician workloads, and improve patient outcomes.
For the full original article on CNBC, please click here: https://www.cnbc.com/2024/10/21/ge-healthcare-announces-time-saving-ai-tool-for-doctors-who-treat-cancer-.html
